Endogenous opiates and behavior: 2022

RJ Bodnar - Peptides, 2023 - Elsevier
This paper is the forty-fifth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

[PDF][PDF] Medical cannabis, headaches, and migraines: A review of the current literature

S Poudel, J Quinonez, J Choudhari, ZT Au, S Paesani… - Cureus, 2021 - cureus.com
Cannabis has been long used since ancient times for both medical and recreational use.
Past research has shown that cannabis can be indicated for symptom management …

Why doctors have a moral imperative to prescribe and support medical cannabis—an essay by David Nutt

D Nutt - bmj, 2022 - bmj.com
Why doctors have a moral imperative to prescribe and support medical cannabis—an essay
by David Nutt | The BMJ Skip to main content Intended for healthcare professionals Access …

Thoughtfully integrating cannabis products into chronic pain treatment

KF Boehnke, CL Wu, DJ Clauw - Anesthesia & Analgesia, 2024 - journals.lww.com
Cannabis products (CPs) and cannabis-based medicines (CBMs) are becoming
increasingly available and are commonly used for pain management. The growing societal …

Medicinal Cannabis Use for Rheumatic Conditions in the US Versus Canada: Rationale for Use and Patient–Health Care Provider Interactions

KF Boehnke, MO Martel, T Smith, Y He… - ACR Open …, 2023 - Wiley Online Library
Objective Understanding how medical cannabis (MC) use is integrated into medical practice
for rheumatic disease management is essential. We characterized rationale for MC use …

Role of Cannabinoids in Oral Cancer

B Cretu, A Zamfir, S Bucurica, AE Scheau… - International Journal of …, 2024 - mdpi.com
Cannabinoids have incited scientific interest in different conditions, including malignancy,
due to increased exposure to cannabis. Furthermore, cannabinoids are increasingly used to …

Characterization of bodily pain and use of both prescription and non-prescription opioids in tenants of precarious housing

M Lei, K Rintoul, JL Stubbs, DD Kim… - Substance Use & …, 2021 - Taylor & Francis
Background opioid use, which includes both prescribed and non-prescribed drugs, is
relatively common amongst marginalized populations. Past research has shown that among …

Patients experiences of therapeutic cannabis consumption in New Zealand

F Hutton, G Noller, A McSherry - Drugs, Habits and Social Policy, 2023 - emerald.com
Purpose This study aims to explore people's experiences of taking cannabis therapeutically
and to gather some real-world evidence (RWE) about the products they were using, their …

Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine

L Pearl-Dowler, L Posa, M Lopez-Canul… - Progress in Neuro …, 2023 - Elsevier
Neuropathic pain (NP) is often treated with opioids, the prolonged use of which causes
tolerance to their analgesic effect and can potentially cause death by overdose. The …

Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients

NK Bekier, U Frischknecht, K Eidenmueller… - European Archives of …, 2024 - Springer
Various studies showed that people with substance use disorder use cannabis to reduce
withdrawal or dose of their main drug. Using a questionnaire about their cannabis use, 118 …